WHO Drug Information - Volume 36, No. 4

Overview

The fourth issue of Volume 36, includes

Pharmaceutical News

• Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis

Consultation Documents

• Lamivudine and tenofovir disoproxil fumarate tablets (lamivudini et tenofoviri disoproxili fumarati compressi)
• Tenofovir disoproxil fumarate tablets (tenofoviri disoproxili fumarati compressi)

ATC/DDD Classification

• Temporary
• Final

International Nonproprietary Names List:

Issue 4 concludes with List N° 128 of Proposed International Nonproprietary Names (INN) for Pharmaceutical Substances. This proposed list contains:

• p.INN list 128 from p. 929 to 1128 (deadline for objecting and commenting is 19 May 2023)
• p.INN list 128 – COVID-19 (special edition - ADDENDUM 2) p. 1134 to 1145 (deadline for objecting and commenting is 19 May 2023)
• p.INN list 128 – COVID-19 (special edition) p. 1129 to 1130 (This part has already been published, deadline for objecting and commenting was 22 August 2022)
• p.INN list 128 – COVID-19 (special edition- ADDENDUM 1) p. 1131 - 1133 (This part has already been published, deadline for objecting and commenting was 29 September 2022)